 |
Neurosearch's PodcastGive it a listen! Author: Neurosearch
Neurosearch is setting new standards in the research of new treatments for Parkinson's disease and other neurodegenerative diseases. Our podcast is intended to provide listeners with a sense of hope and a better understanding of the exciting work that Neurosearch researchers are engaged in to fight neurodegenerative diseases. Language: en-us Genres: Health & Fitness, Medicine Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
Season 2 Episode 2 - Depression in Parkinson's disease
Friday, 6 March, 2009
In today’s episode, Neurologist, Robert M. Hutchman, MD, MDS, discusses Depression in Parkinson’s disease. Some studies indicate that anywhere from 40% to 60% of PD suffers experience clinically significant depression. Several recent research efforts have examined the efficacy of treating depression in PD with medications that approach mood stabilization differently. Some recent research is discussed that indicates depression in the Parkinson’s disease may have a different pathology that requires a different treatment approach. Tricyclic Anti-depressants (TCA), Selective Serotonin Reuptake Inhibitors (SSRI), and a relatively new class of extended release atypical anti-depressants called norepinephrine and dopamine reuptake inhibitor (NDRI) are discussed in today’s episode. As Dr. Hutchman explains, the objective is to find the best medication to treat these complex issues. Does new medical research hold the answer to better treatments? Listen and find out.
